EUVIMEDEUVIMED entdecken
Crossref

Activity of ceftazidime-avibactam combinations against carbapenem-resistant Klebsiella pneumoniae assessed by checkerboard method

Serpil Genç iD, Ayten Nur Uzun, Hilal Tanriverdi

Acta Microbiologica et Immunologica Hungarica · 2025

DOI: 10.1556/030.2025.02686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2025. Verfasst von Serpil Genç und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Medical Microbiology, Kütahya Health Sciences University, Kütahya, Türkiye. Hauptthemen laut MEDLINE: Ceftazidime, Azabicyclo Compounds, Klebsiella pneumoniae, Anti-Bacterial Agents. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study is to detect the carbapenemase type and to determine the in vitro effects of ceftazidime/avibactam-colistin, ceftazidime/avibactam-meropenem and ceftazidime/avibactam-tigecycline combinations against Carbapenem-Resistant Klebsiella pneumoniae (CRKP) isolates. A total of 35 CRKP isolates were included to the study. The minimum inhibitory concentrations of ceftazidime/avibactam, meropenem, colistin and tigecycline were determined by broth dilution method. Synergistic effects of ceftazidime/avibactam-colistin, ceftazidime/avibactam-meropenem and ceftazidime/avibactam-tigecycline were investigated by microdilution checkerboard method. Carbapenemase genes ( bla OXA-48 , bla NDM , bla KPC , bla IMP , bla VIM ) were detected by multiplex PCR. All of the isolates were resistant to meropenem, whereas 77.1% of the isolates were resistant to ceftazidime/avibactam and 14.3% of the isolates were resistant to colistin. The carbapenemase genes of the CRKP isolates were determined as 17 OXA-48+NDM, 9 KPC, 6 OXA-48, 1 NDM, 1 KPC+NDM and 1 KPC+OXA-48. Ceftazidime/avibactam-colistin, ceftazidime/avibactam-meropenem and ceftazidime/avibactam-tigecycline combinations were synergistic against 5.7% (2/35), 17.1% (6/35), and 5.7% (2/35) of the isolates, respectively. Ceftazidime/avibactam-meropenem was the most effective synergistic combination in our study, showing synergism in 17.1% of isolates, however, the synergistic effect varied depending on the CRKP isolate tested.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftazidimeAzabicyclo CompoundsKlebsiella pneumoniaeAnti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeDrug CombinationsMicrobial Sensitivity TestsHumansBacterial ProteinsKlebsiella Infectionsbeta-LactamasesDrug SynergismDrug Resistance, Multiple, BacterialCarbapenemsColistin

Stichwörter der Autor:innen

carbapenem-resistant K. pneumoniaeceftazidime/avibactamcolistinsynergytigecycline

Substanzen

CeftazidimeAzabicyclo CompoundsAnti-Bacterial Agentsavibactam, ceftazidime drug combinationDrug CombinationsBacterial Proteinscarbapenemasebeta-LactamasesCarbapenemsColistin

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Medical Microbiology, Kütahya Health Sciences University, Kütahya, Türkiye.

ORCID-Profile: Serpil Genç

Zitieren

APA

Genç, S., Uzun, A. N., & Tanriverdi, H. (2025). Activity of ceftazidime-avibactam combinations against carbapenem-resistant Klebsiella pneumoniae assessed by checkerboard method. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2025.02686

Vancouver

Genç S, Uzun AN, Tanriverdi H. Activity of ceftazidime-avibactam combinations against carbapenem-resistant Klebsiella pneumoniae assessed by checkerboard method. Acta Microbiologica et Immunologica Hungarica. 2025. doi:10.1556/030.2025.02686

BibTeX
@article{Gen2025,
  author = {Genç, Serpil and Uzun, Ayten Nur and Tanriverdi, Hilal},
  title = {Activity of ceftazidime-avibactam combinations against carbapenem-resistant Klebsiella pneumoniae assessed by checkerboard method},
  journal = {Acta Microbiologica et Immunologica Hungarica},
  year = {2025},
  doi = {10.1556/030.2025.02686}
}
Kostenlos starten →